What podcasts say about Will Heyburn

Every statement, with the speaker, the exact quote and the moment it was said.

What Will Heyburn has said on podcasts

17 statements · 16 positive · 1 neutral

on Strata Critical clinical businessPositiveSep 30, 2026· MicroCapClub
Strata’s clinical business grew more than 20% quarter over quarter recently.
“The clinical part of our business grew nearly 20%, more than 20% quarter over quarter in the most recent quarter.”
Listen at 4:31
Open the episode · Strata Critical Medical (SRTA): The Organ Transplant Logistics Roll-Up
on Strata CriticalPositiveSep 30, 2026· MicroCapClub
Strata is adjusted EBITDA and free-cash-flow positive.
“We're adjusted EBITDA and free cash flow positive”
Listen at 4:38
Open the episode · Strata Critical Medical (SRTA): The Organ Transplant Logistics Roll-Up
on Strata CriticalPositiveSep 30, 2026· MicroCapClub
Strata plans acquisitions to expand its national footprint alongside organic growth.
“we're executing incrementally to this strong organic growth on a plan of acquisitions to continue to build our national footprint”
Listen at 4:41
Open the episode · Strata Critical Medical (SRTA): The Organ Transplant Logistics Roll-Up
on Strata CriticalPositiveSep 30, 2026· MicroCapClub
Strata’s integrated services can solve the organ-transplant supply problem.
“This is entirely a supply problem, and in our view, it's a supply problem that can be solved by putting the pieces of the puzzle together that we provide at Strata.”
Listen at 5:57
Open the episode · Strata Critical Medical (SRTA): The Organ Transplant Logistics Roll-Up
on Strata CriticalPositiveSep 30, 2026· MicroCapClub
Strata believes it is unique in the transplant-services industry.
“we really believe we're one of a kind in this industry”
Listen at 7:59
Open the episode · Strata Critical Medical (SRTA): The Organ Transplant Logistics Roll-Up
on Strata CriticalPositiveSep 30, 2026· MicroCapClub
Delaying aircraft activation until organ acceptance can reduce transplant logistics costs.
“we can save a lot of money for transplant centers and for the system if we wait to turn on expensive airplanes until we know that those organs are going to be utilized.”
Listen at 10:21
Open the episode · Strata Critical Medical (SRTA): The Organ Transplant Logistics Roll-Up
on Normothermic regional perfusionPositiveSep 30, 2026· MicroCapClub
Normothermic regional perfusion produces 50% more usable organs per donor on average.
“resulting in, on average, 50% more usable organs per organ donor”
Listen at 11:43
Open the episode · Strata Critical Medical (SRTA): The Organ Transplant Logistics Roll-Up
on Donation after circulatory deathPositiveSep 30, 2026· MicroCapClub
Donation after circulatory death has grown around 20% annually in recent years.
“has been growing consistently in the 20% range over the last several years.”
Listen at 12:05
Open the episode · Strata Critical Medical (SRTA): The Organ Transplant Logistics Roll-Up
on Continuous distribution organ allocationPositiveSep 30, 2026· MicroCapClub
Organ allocation is planned to shift toward continuous distribution prioritizing patient sickness.
“The plan is to move to what's called continuous distribution, a national allocation methodology that focuses primarily on the sickness of the patient”
Listen at 12:49
Open the episode · Strata Critical Medical (SRTA): The Organ Transplant Logistics Roll-Up
on Lung continuous distributionNeutralSep 30, 2026· MicroCapClub
Continuous distribution increased lung donor-recipient distances by nearly 80%.
“When we saw lungs move from acuity circles to continuous distribution, we saw a nearly 80% increase in the distance between donors and recipients.”
Listen at 13:01
Open the episode · Strata Critical Medical (SRTA): The Organ Transplant Logistics Roll-Up
on Strata CriticalPositiveSep 30, 2026· MicroCapClub
Strata’s business model will benefit from faster-growing transplant segments and longer trips.
“our business model is more exposed to those faster-growing parts of the transplant industry and will benefit from those longer trips that we talked about”
Listen at 13:54
Open the episode · Strata Critical Medical (SRTA): The Organ Transplant Logistics Roll-Up
on Strata CriticalPositiveSep 30, 2026· MicroCapClub
Strata has acquired four smaller regional players year to date.
“we've made 4 year to date of smaller regional players”
Listen at 14:51
Open the episode · Strata Critical Medical (SRTA): The Organ Transplant Logistics Roll-Up
on Donor-recipient organ travel distancePositiveSep 30, 2026· MicroCapClub
Donor-recipient travel distances have increased about 68%.
“we've already seen about a 68% increase as these regulations have continued to evolve and as perfusion technology has allowed us to extend the distance that we can travel with these donor organs.”
Listen at 15:07
Open the episode · Strata Critical Medical (SRTA): The Organ Transplant Logistics Roll-Up
on Strata CriticalPositiveSep 30, 2026· MicroCapClub
Strata is well capitalized and positioned to acquire quality regional providers.
“we're very well capitalized and we're very well positioned to find attractive, quality regional providers”
Listen at 17:08
Open the episode · Strata Critical Medical (SRTA): The Organ Transplant Logistics Roll-Up
on Strata CriticalPositiveSep 30, 2026· MicroCapClub
Strata’s completed and pipeline acquisitions carry mid-single-digit EBITDA multiples.
“mid-single-digit adjusted EBITDA acquisition multiples for all of the acquisitions that we've completed to date and for everything that's in our pipeline today.”
Listen at 17:43
Open the episode · Strata Critical Medical (SRTA): The Organ Transplant Logistics Roll-Up
on Strata CriticalPositiveSep 30, 2026· MicroCapClub
Strata continues to grow attractively, especially in clinical services.
“The company continues to grow attractively, particularly in our clinical business.”
Listen at 19:33
Open the episode · Strata Critical Medical (SRTA): The Organ Transplant Logistics Roll-Up
on Strata Critical transplant clinical businessPositiveSep 30, 2026· MicroCapClub
Strata’s transplant clinical business grew 22% organically and 27% including acquisitions quarter over quarter.
“You see 22% organic quarter-over-quarter growth, 27% when you include the benefit of our acquisitions on that transplant clinical business.”
Listen at 19:38
Open the episode · Strata Critical Medical (SRTA): The Organ Transplant Logistics Roll-Up

Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.